Hill-Rom Holdings Inc. (NYSE:HRC) – Analysts at KeyCorp issued their Q1 2017 earnings estimates for shares of Hill-Rom Holdings in a research note issued on Sunday. KeyCorp analyst M. Mishan forecasts that the brokerage will post earnings per share of $0.76 for the quarter. KeyCorp also issued estimates for Hill-Rom Holdings’ Q2 2017 earnings at $0.84 EPS, Q3 2017 earnings at $0.93 EPS, Q4 2017 earnings at $1.25 EPS, FY2017 earnings at $3.78 EPS and FY2018 earnings at $4.15 EPS.

Separately, Zacks Investment Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Wednesday. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Hill-Rom Holdings has a consensus rating of “Buy” and a consensus target price of $62.20.

Earnings History and Estimates for Hill-Rom Holdings (NYSE:HRC)

Shares of Hill-Rom Holdings (NYSE:HRC) opened at 53.55 on Tuesday. The company’s 50-day moving average is $59.19 and its 200 day moving average is $54.47. Hill-Rom Holdings has a 52 week low of $42.99 and a 52 week high of $63.12. The stock has a market capitalization of $3.58 billion, a P/E ratio of 28.79 and a beta of 1.20.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Thursday, November 3rd. The medical technology company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.05. Hill-Rom Holdings had a net margin of 4.67% and a return on equity of 18.93%. The firm had revenue of $706 million for the quarter, compared to the consensus estimate of $701.39 million. During the same period in the prior year, the firm earned $0.89 EPS. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis.

Several large investors have recently added to or reduced their stakes in HRC. FMR LLC boosted its stake in Hill-Rom Holdings by 45.0% in the second quarter. FMR LLC now owns 5,017,977 shares of the medical technology company’s stock valued at $253,157,000 after buying an additional 1,557,285 shares in the last quarter. Highbridge Capital Management LLC bought a new stake in Hill-Rom Holdings during the second quarter valued at about $17,766,000. Bank of Montreal Can bought a new stake in Hill-Rom Holdings during the second quarter valued at about $15,483,000. Cooke & Bieler LP bought a new stake in Hill-Rom Holdings during the second quarter valued at about $15,035,000. Finally, BlackRock Fund Advisors boosted its stake in Hill-Rom Holdings by 12.0% in the second quarter. BlackRock Fund Advisors now owns 2,352,117 shares of the medical technology company’s stock valued at $118,664,000 after buying an additional 252,239 shares in the last quarter. 83.10% of the stock is currently owned by institutional investors and hedge funds.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

5 Day Chart for NYSE:HRC

Receive News & Stock Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related stocks with our FREE daily email newsletter.